전체 프로그램

CGTBiologicstaleJuno Therapeutics, Inc., a Bris…Phase 1

임상시험 2상태 DISCONTINUED

Autologous Human Anti-CD19CAR-4-1BB-CD3zeta-EGFRt-expressing CD4+/CD8+ T-lymphocytes (Autologous Human Anti-CD19CAR-4-1BB-CD3zeta-EGFRt-expressing CD4+/CD8+ T-lymphocytes)

Recurrent Adult Acute Lymphoblastic Leukemia; Recurrent B-Cell Non-Hodgkin Lymphoma · EGFR

#EGFR#CGT#Phase1#세포유전치료#CAR-T+4

효능 ORR 1%임상시험 2상태 DISCONTINUED

CGTBiologicstaleAutolus LimitedPhase 2

CAR-T cells targeting CD19 and CD22 (CAR-T cells targeting CD19 and CD22)

B-Cell Acute Lymphoblastic Leukemia, Adult · CD19

CGTBiologicstaleAthenex, Inc.Phase 1

효능 ORR 1%임상시험 2상태 RECRUITING

CD19 CAR T-cell (CD19 CAR T-cell)

Membranous Nephropathy; Lupus Nephritis (LN) · CD19

CGTBiologicstaleTimmune Biotech Inc.Phase 1

효능 ORR 67%임상시험 2상태 RECRUITING

CD19-TriCAR-T/SILK (CD19-TriCAR-T/SILK)

Non-Hodgkin Lymphoma of Intestine; Leukemia · CD19

CGTBiologicstaleShanghai Ming Ju Biotechnology …Phase 2

임상시험 2상태 ACTIVE

CD19-targeted Chimeric Antigen Receptor (CAR, CD19-targeted Chimeric Antigen Receptor, CD19-targeted Chimeric Antigen Receptor (CAR) T Cells)

Lymphoma, Non-Hodgkin; Diffuse Large B Cell Lymphoma · CD19

#CD19#CGT#Phase2#세포유전치료#CAR-T+5

효능 ORR 94%임상시험 2상태 ACTIVE

CGTBiologicstaleEssen BiotechPhase 2

CD19/BCMA CAR T-cells (CD19/BCMA CAR T-cells)

Systemic Lupus Erythematosus; Lupus Nephritis · CD19

CGTBiologicstaleLiping DouPhase 2

CD22/CD19 Dual-Target CAR-T Cells (CD22/CD19 Dual-Target CAR-T Cells)

B-cell Acute Lymphoblastic Leukemia · CD19

#CD19#CGT#Phase2#세포유전치료#CAR-T+3

CGTBiologicstaleHan weidongPhase 2

Decitabine-primed Tandem CAR19/20 engineered T cells (Decitabine-primed Tandem CAR19/20 engineered T cells)

Refractory or Relapsed Aggressive r/r B-NHL With Huge Tumor Burden · CD19

CGTBiologicstaleNanjing Legend Biotech Co.Phase 2

Dual Specificity CD19 and CD22 CAR-T Cell Immunotherapy (Dual Specificity CD19 and CD22 CAR-T Cell Immunotherapy)

Lymphoma, B-Cell · CD19

CGTBiologicstaleRui Therapeutics Co., LtdPhase 1

임상시험 2상태 ACTIVE

Fludarabine + Cyclophosphamide + CAR-NK-CD19 Cells (Fludarabine + Cyclophosphamide + CAR-NK-CD19 Cells)

Acute Lymphoblastic Leukemia; Chronic Lymphoblastic Leukemia · CD19

CGTBiologicstaleUniversity College, LondonPhase 1

효능 ORR 0%임상시험 2상태 ACTIVE

4G7-CARD T-cells (Infusion of modified CAR19 T-cells, Infusion of modified CAR19 T-cells (4G7-CARD T-cells))

CD19+ Malignancies: Relapse Post-allogeneic Transplant · CD19

#CD19#CGT#Phase1#세포유전치료#CAR-T+3

효능 ORR 77.3%임상시험 2상태 ACTIVE

CGTBiologicstaleKyverna TherapeuticsPhase 2

KYV-101 anti-CD19 CAR-T cell therapy (KYV-101 anti-CD19 CAR-T cell therapy)

Lupus Nephritis; Lupus Nephritis - World Health Organization (WHO) Class III · CD19

CGTBiologicstaleKecellitics Biotech Company LtdPhase 1

anti-CD19 CAR (anti-CD19 CAR)

Leukemia · CD19

#CD19#CGT#Phase1#세포유전치료#CAR-T+3

효능 ORR 94%임상시험 2상태 ACTIVE

CGTBiologicstaleKite, A Gilead CompanyPhase 1

anti-CD19 CAR-T (anti-CD19 CAR-T)

B-cell Adult Acute Lymphoblastic Leukemia; B-cell Chronic Lymphocytic Leukemia · CD19

CGTBiologicstaleCity of Hope Medical CenterPhase 1

효능 ORR 94%임상시험 2상태 ACTIVE

autologous CD19CAR-CD28-CD3zeta-EGFRt-expressing Tcm-enriched T cells (autologous CD19CAR-CD28-CD3zeta-EGFRt-expressing Tcm-enriched T cells)

Adult Grade III Lymphomatoid Granulomatosis; Cutaneous B-cell Non-Hodgkin Lymphoma · EGFR

#EGFR#CGT#Phase1#세포유전치료#CAR-T+4

CGTBiologicstaleAbClonPhase 2

Anti-CD19 Chimeric Antigen Receptor T cell (AT101, AT101(Anti-CD19 Chimeric Antigen Receptor T cell))

B-cell Non Hodgkin Lymphoma · CD19

#CD19#CGT#Phase2#세포유전치료#CAR-T+3

CGTBiologicstaleThe First Affiliated Hospital o…Preclinical

Anti-BCMA and CD19 CART cells will be injected intravenously on a one-time basis. (Anti-BCMA and CD19 CART cells will be injected intravenously on a one-time basis.)

Autoimmune Diseases · CD19

#CD19#CGT#Preclinical#세포유전치료#CAR-T+3

CGTBiologicstaleChinese PLA General HospitalPhase 2

Anti-BCMA-CD19 CAR-T cells (Anti-BCMA-CD19 CAR-T cells)

IgG4 Related Disease; B-cell Mediated Autoimmune Disorders · CD19

CGTBiologicstaleTakedaPhase 2

Anti-CD19 CAR T Cells Preparation (Anti-CD19 CAR T Cells Preparation)

Hematologic Malignancies · CD19

#CD19#CGT#Phase2#세포유전치료#CAR-T+3